Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 11;14(10):2367.
doi: 10.3390/cancers14102367.

Radiological Underestimation of Tumor Size as a Relevant Risk Factor for Positive Margin Rate in Breast-Conserving Therapy of Pure Ductal Carcinoma In Situ (DCIS)

Affiliations

Radiological Underestimation of Tumor Size as a Relevant Risk Factor for Positive Margin Rate in Breast-Conserving Therapy of Pure Ductal Carcinoma In Situ (DCIS)

Gesche Schultek et al. Cancers (Basel). .

Abstract

Background: Radiological underestimation of the actual tumor size is a relevant problem in reaching negative margins in ductal carcinoma in situ (DCIS) associated with microcalcifications in breast-conserving therapy (BCT). The aim of this study is to evaluate whether the radiological underestimation of tumor size has an influence on the histopathological margin status. Methods: Patients who underwent BCT with preoperatively diagnosed pure DCIS were included (pooled analysis of two trials). Multiple factors were analysed regarding radiological underestimation ≥10 mm. Radiological underestimation was defined as mammographic minus histological tumor size in mm. Results: Positive margins occurred in 75 of 189 patients. Radiological underestimation ≥10 mm was an independent influencing factor (OR 5.80; 95%CI 2.55−13.17; p < 0.001). A radiological underestimation was seen in 70 patients. The following parameters were statistically significant associated with underestimation: pleomorphic microcalcifications (OR 3.77; 95%CI 1.27−11.18), clustered distribution patterns (OR 4.26; 95%CI 2.25−8.07), and mammographic tumor sizes ≤20 mm (OR 7.47; 95%CI 3.49−15.99). Only a mammographic tumor size ≤20 mm was an independent risk factor (OR 6.49; 95%CI 2.30−18.26; p < 0.001). Grading, estrogen receptor status, and comedo necrosis did not influence the size estimation. Conclusion: Radiological underestimation is an independent risk factor for positive margins in BCT of DCIS associated with microcalcifications predominantly occurring in mammographic small tumors.

Keywords: breast-conserving surgery; ductal carcinoma in situ; positive margin rate; radiological underestimation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Radiological underestimation influencing the surgical result.
Figure 2
Figure 2
Relationship between mammographic size and radiological underestimation.

References

    1. Rauch G.M., Hobbs B.P., Kuerer H.M., Scoggins M.E., Benveniste A.P., Park Y.M., Caudle A.S., Ms P.S.F., Smith B.D., Adrada B.E., et al. Microcalcifications in 1657 Patients with Pure Ductal Carcinoma In Situ of the Breast: Correlation with Clinical, Histopathologic, Biologic Features, and Local Recurrence. Ann. Surg. Oncol. 2015;23:482–489. doi: 10.1245/s10434-015-4876-6. - DOI - PMC - PubMed
    1. Canelo-Aybar C., Taype-Rondan A., Zafra-Tanaka J.H., Rigau D., Graewingholt A., Lebeau A., Gómez E.P., Rossi P.G., Langendam M., Posso M., et al. Preoperative breast magnetic resonance imaging in patients with ductal carcinoma in situ: A systematic review for the European Commission Initiative on Breast Cancer (ECIBC) Eur. Radiol. 2021;31:5880–5893. doi: 10.1007/s00330-021-07873-2. - DOI - PMC - PubMed
    1. Benson J.R., Wishart G.C. Predictors of recurrence for ductal carcinoma in situ after breast-conserving surgery. Lancet Oncol. 2013;14:e348–e357. doi: 10.1016/S1470-2045(13)70135-9. - DOI - PubMed
    1. Szucs Z., Joseph J., Larkin T.J., Xie B., Bohndiek S.E., Brindle K.M., Neves A.A. Multi-modal imaging of high-risk ductal carcinoma in situ of the breast using C2Am: A targeted cell death imaging agent. Breast Cancer Res. 2021;23:25. doi: 10.1186/s13058-021-01404-z. - DOI - PMC - PubMed
    1. Yip C.-H. Difficulty of Achieving Clear Margins in Nonpalpable Ductal Carcinoma of the Breast. JAMA Surg. 2017;152:385. doi: 10.1001/jamasurg.2016.4752. - DOI - PubMed

LinkOut - more resources